Cardiovascular protective effect of melatonin in sudden unexpected death in epilepsy: A hypothesis

Medical Hypotheses

Volumn 70, Issue 3, 2008, Pages 605-609

  Scorza, Fulvio A ^a   Colugnati, Diego B ^a   Arida, Ricardo M ^a   de Lima, Eliângela ^a   da Graça Naffah Mazzacoratti, Maria ^a   Cavalheiro, Esper A ^a   Amado, Débora ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cardiac abnormalities; Epilepsy; Melatonin; Sudden unexpected death in epilepsy

Indexed keywords

GLUTAMIC ACID; LAMOTRIGINE; MELATONIN;

ANTIARRHYTHMIC ACTIVITY; ARTICLE; CLINICAL TRIAL; DISEASE DURATION; DRUG EFFECT; ELECTRIC SHOCK; EPILEPSY; HEART PROTECTION; HUMAN; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR; SEASONAL VARIATION; SUDDEN DEATH;

CARDIOTONIC AGENTS; DEATH, SUDDEN; EPILEPSY; HUMANS; MELATONIN; MODELS, BIOLOGICAL; RISK FACTORS; SEIZURES;

RATTUS; RODENTIA;

EID: 38749126227     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.04.048     Document Type: Article

References (58)

1. Sander J.W. The epidemiology of epilepsy revisited. Curr Opin Neurol 16 (2003) 165-170
2. Begley C.E., Annegers J.F., Lairson L.B., and Reynolds T.F. Epilepsy incidence, prognosis, and use of medical care in Houston, Texas, and Rochester, Minnesota. Epilepsia 39 Suppl. 6 (1998) 222
3. Annegers J.F. Epidemiology of epilepsy. In: Wyllie E. (Ed). The treatment of epilepsy: principles and practice. 2nd ed. (1997), Williams & Wilkins, Baltimore 65-172
4. Yuen A.W., and Sander J.W. Is omega-3 fatty acid deficiency a factor contributing to refractory seizures and SUDEP? A hypothesis. Seizure 13 (2004) 104-107
5. Sander J.W. Some aspects of prognosis in the epilepsies: a review. Epilepsia 34 (1993) 1007-1016
6. Kwan P., and Sander J.W. The natural history of epilepsy: an epidemiological view. J Neurol Neurosurg Psychiatry 75 (2004) 1376-1381
7. Halatchev V.N. Epidemiology of epilepsy - recent achievements and future. Folia Medica (Plovdiv) 42 (2000) 17-22
8. Duncan J.S., Sander J.W., Sisodiya S.M., and Walker M.C. Adult epilepsy. Lancet 367 (2006) 1087-1100
9. Dichter M.A. Emerging insights into mechanisms of epilepsy: implications for new antiepileptic drug development. Epilepsia 35 Suppl. 4 (1994) S51-S57
10. Dalby N.O., and Mody I. The process of epileptogenesis: a pathophysiological approach. Curr Opin Neurol 14 (2001) 187-192
11. Babb T.L. Synaptic reorganizations in human and rat hippocampal epilepsy. Adv Neurol 79 (1999) 763-779
12. Engel Jr. J. Clinical neurophysiology, neuroimaging, and the surgical treatment of epilepsy. Curr Opin Neurol Neurosurg 6 (1993) 240-249
13. Cendes F., Andermann F., Dubeau F., Gloor P., Evans A., Jones-Gotman M., et al. Early childhood prolonged febrile convulsions, atrophy and sclerosis of mesial structures, and temporal lobe epilepsy: an MRI volumetric study. Neurology 43 (1993) 1083-1087
14. Nashef L. Sudden unexpected death in epilepsy: terminology and definitions. Epilepsia 38 (1997) S6-S8
15. Tomson T., Walczak T., Sillanpaa M., and Sander J.W. Sudden unexpected death in epilepsy: a review of incidence and risk factors. Epilepsia 46 Suppl. 11 (2005) 54-61
16. Leestma J.E., Annegers J.F., Brodie M.J., Brown S., Schraeder P., Siscovick D., et al. Sudden unexplained death in epilepsy: observations from a large clinical development program. Epilepsia 38 (1997) 47-55
17. Tennis P., Cole T.B., Annegers J.F., Leestma J.E., McNutt M., and Rajput A. Cohort study of incidence of sudden unexplained death in persons with seizure disorder treated with antiepileptic drugs in Saskatchewan, Canada. Epilepsia 36 (1995) 29-36
18. Nashef L., Fish D.R., Sander J.W., and Shorvon S.D. Incidence of sudden unexpected death in an adult outpatient cohort with epilepsy at a tertiary referral centre. J Neurol Neurosurg Psychiatry 58 (1995) 462-464
19. Ficker D.M., So E.L., Shen W.K., Annegers J.F., O'Brien P.C., and Cascino G.D. Population-based study of the incidence of sudden unexplained death in epilepsy. Neurology 515 (1998) 1270-1274
20. Lhatoo S.D., and Sander J.W. The epidemiology of epilepsy and learning disability. Epilepsia 42 Suppl. 1 (2001) 6-9 discussion 19-20
21. Medical Research Council. Antiepileptic Drug Withdrawal Study Group. Randomised study of antiepileptic drug withdrawal in patients in remission. Lancet 1991;337:1175-1180.
22. Nilsson L., Farahmand B.Y., Persson P.G., Thiblin I., and Tomson T. Risk factors for sudden unexpected death in epilepsy: a case-control study. Lancet 353 (1999) 888-893
23. Walczak T.S., Leppik I.E., D'Amelio M., Rarick J., So E., Ahman P., et al. Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study. Neurology 56 (2001) 519-525
24. Sperling M.R., Feldman H., Kinman J., Liporace J.D., and O'Connor M.J. Seizure control and mortality in epilepsy. Ann Neurol 46 (1999) 45-50
25. Langan Y., Nashef L., and Sander J.W. Case-control study of SUDEP. Neurology 64 (2005) 1131-1133
26. Kloster R., and Engelskjon T. Sudden unexpected death in epilepsy (SUDEP): a clinical perspective and a search for risk factors. J Neurol Neurosurg Psychiatry 67 (1999) 439-444
27. Nilsson L., Bergman U., Diwan V., Farahmand B.Y., Persson P.G., and Tomson T. Antiepileptic drug therapy and its management in sudden unexpected death in epilepsy: a case-control study. Epilepsia 42 (2001) 667-673
28. Scorza F.A., de Albuquerque M., Arida R.M., and Cavalheiro E.A. Sudden unexpected death in epilepsy: Are winter temperatures a new potential risk factor?. Epilepsy Behav 10 3 (2007) 509-510
29. Stollberger C., and Finsterer J. Cardiorespiratory findings in sudden unexplained/unexpected death in epilepsy (SUDEP). Epilepsy Res 59 (2004) 51-60
30. Sanabria E.R., Scorza F.A., Bortolotto Z.A., Calderazzo-Filho L.S., and Cavalheiro E.A. Disruption of light-induced c-Fos immunoreactivity in the suprachiasmatic nuclei of chronic epileptic rats. Neurosci Lett 216 (1996) 105-108
31. Martins da Silva A., Aartes J.H.P., and Binniew C.D. The circadian distribution of interictal epileptiform EEG activity. Eletroencephalogr Clin Neurophysiol 58 (1984) 1-13
32. Reiter R.J. Normal patterns of melatonin levels in the pineal gland and body fluids of humans and experimental animals. J Neural Transm 21 (1986) 35-54
33. Lapin I.P., Mirzaev S.M., Ryzon I.V., and Oxenkrug G.F. Anticonvulsant activity of melatonin against seizures induced by quinolinate, kainate, glutamate, NMDA, and pentilenotetrazole in mice. J Pineal Res 24 (1998) 215-218
34. Yamamoto H.A., and Tang H.W. Melatonin attenuates l-cysteine-induced seizures and peroxidation lipid in the brain of mice. J Pineal Res 21 (1996) 108-113
35. Yehuda S., and Mostofsky D.I. Circadian effects of β-endorphin, melatonin, DSIP, and amphetamine on pentylenotetrazole-induced seizures. Peptides 14 (1993) 203-205
36. Mevissen M., and Ebert U. Anticonvulsivant effects of melatonin in amygdala-kindled rats. Neurosci Lett 257 (1998) 13-16
37. Albertson T.E., Peterson S.L., Stark L.G., Lakin M.L., and Winters W.D. The anticonvulsant properties of melatonin on kindled seizures in rats. Neuropharmacology 20 (1981) 61-66
38. Anton-Tay F. Melatonin: effects on brain function. Adv Biochem Psychopharmacol 11 (1974) 315-324
39. Peled N., Shorer Z., Peled E., and Pillar G. Melatonin effect on seizures in children with severe neurologic deficit disorders. Epilepsia 42 (2001) 1208-1210
40. Bazil C.W., Short D., Crispin D., and Zheng W. Patients with intractable epilepsy have low melatonin, which increases following seizures. Neurology 55 (2000) 1746-1748
41. Uz T., Giusti D., Franceschini D., Kharlamov A., and Manev H. Protective effect of melatonin against hippocampal DNA damage induced by intraperitoneal administration of kainate to rats. Neuroscience 73 (1996) 631-636
42. Wu F.S., Yang Y.C., and Tsai J.J. Melatonin potentiates the GABAA receptor-mediated current in cultured chick spinal cord neurons. Neurosci Lett 260 (1999) 177-180
43. Molina-Carballo A., Munoz-Hoyos A., Rodriguez-Cabezas T., and Acuna-Castroviejo D. Day-night variations in melatonin secretion by pineal gland during febrile and epileptic convulsions in children. Psychiatry Res 52 (1994) 273-283
44. Chung S.Y., and Han S.H. Melatonin attenuates kainic acid-induced hippocampal neurodegeneration and oxidative stress through microglial inhibition. J Pineal Res 34 (2003) 95-102
45. de Lima E., Soares Jr. J.M., del Carmen Sanabria Garrido Y., Gomes Valente S., Priel M.R., Chada Baracat E., et al. Effects of pinealectomy and the treatment with melatonin on the temporal lobe epilepsy in rats. Brain Res. 1043 (2005) 24-31
46. Reiter R.J., Tan D.X., Pilar Terron M., Flores L.J., and Czarnocki Z. Melatonin and its metabolites: new findings regarding their production and their radical scavenging actions. Acta Biochim Pol 54 (2007) 1-9
47. Tan D.X., Manchjester L.C., Reiter R.J., et al. Ischemia/reperfusion-induced arrhythmias in the isolated rat heart: prevention by melatonin. J Pineal Res 25 (1998) 184-191
48. Szarszoi O., Asemu G., Vanecek J., et al. Effects of melatonin on ischemia and reperfusion injury of the rat heart. Cardiovasc Drugs Ther 5 (2001) 251-257
49. Lagneux C., Joyeux M., Demenge P., et al. Protective effect of melatonin against ischemia-reperfusion injury in the isolated rat heart. Life Sci 66 (2000) 503-509
50. K-Laflamme A., Wu L., Foucart S., and Champlain D.J. Impaired basal sympathetic tone and alpha1-adrenergic responsiveness in association with the hypotensive effect of melatonin in spontaneously hypertensive rats. Am J Hypertens 32 (1998) 219-229
51. Marktl W., Brugger P., and Herold M. Melatonin and coronary heart disease. Wien Klin Wochenschr 32 (1997) 747-749
52. Hohnloser S.H., Zabel M., Olschewski M., Kasper W., and Just M. Arrhythmias during the acute phase of reperfusion therapy for acute myocardial infarction: effects of beta-adrenergic blockade. Am Heart J 32 (1992) 1530-1535
53. Brzezinski A. Melatonin in humans. N Engl J Medical 32 (1997) 186-195
54. Muller J.E., Ludmer P.L., Willich S.N., et al. Circadian variation in the frequency of sudden cardiac death. Circulation 32 (1987) 131-138
55. Sparks D.L., and Hunsaker III J.C. The pineal gland in sudden infant death syndrome: preliminary observations. J Pineal Res 5 1 (1988) 111-118
56. Sturner W.Q., Lynch H.J., Deng M.H., Gleason R.E., and Wurtman R.J. Melatonin concentrations in the sudden infant death syndrome. Forensic Sci Int 45 (1990) 171-180
57. Maurizi C.P. Could exogenous melatonin prevent sudden infant death syndrome?. Med Hypotheses 49 (1997) 425-427
58. Colugnati D.B., Gomes P.A., Arida R.M., et al. Avaliação de parâmetros cardíacos em animais com epilepsia: possível causa de morte súbita? [Analysis of cardiac parameters in animals with epilepsy: possible cause of sudden death?]. Arq Neuropsiquiatr 63 (2005) 1035-1041